Dudley & Shanley Inc. decreased its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 7.1% in the third quarter, HoldingsChannel reports. The institutional investor owned 64,550 shares of the medical research company’s stock after selling 4,950 shares during the period. Agilent Technologies comprises approximately 1.8% of Dudley & Shanley Inc.’s holdings, making the stock its 23rd largest position. Dudley & Shanley Inc.’s holdings in Agilent Technologies were worth $11,123,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in A. Eastern Bank raised its stake in shares of Agilent Technologies by 12.9% during the third quarter. Eastern Bank now owns 2,819 shares of the medical research company’s stock valued at $486,000 after acquiring an additional 323 shares in the last quarter. QRG Capital Management Inc. grew its stake in Agilent Technologies by 7.6% in the second quarter. QRG Capital Management Inc. now owns 49,576 shares of the medical research company’s stock worth $6,585,000 after purchasing an additional 3,503 shares in the last quarter. Envestnet Asset Management Inc. increased its holdings in Agilent Technologies by 36.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 943,900 shares of the medical research company’s stock worth $125,378,000 after purchasing an additional 250,989 shares during the period. State Street Corp raised its position in Agilent Technologies by 0.7% during the 2nd quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock valued at $1,710,658,000 after purchasing an additional 89,598 shares in the last quarter. Finally, The Manufacturers Life Insurance Company raised its position in Agilent Technologies by 9.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 163,805 shares of the medical research company’s stock valued at $21,758,000 after purchasing an additional 14,435 shares in the last quarter. 87.41% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Agilent Technologies
In related news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the transaction, the director directly owned 4,924 shares in the company, valued at $745,395.12. The trade was a 11.41% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.17% of the stock is owned by insiders.
Agilent Technologies Stock Down 0.9%
Agilent Technologies (NYSE:A – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the previous year, the firm earned $1.37 EPS. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 6.2 EPS for the current year.
Agilent Technologies Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th will be issued a dividend of $0.2550 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, October 6th. Agilent Technologies’s dividend payout ratio is currently 20.08%.
Analyst Upgrades and Downgrades
A number of equities analysts have recently issued reports on A shares. Piper Sandler started coverage on Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target on the stock. UBS Group began coverage on shares of Agilent Technologies in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $165.00 price objective for the company. Barclays increased their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a report on Thursday, August 27th. Wall Street Zen lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Royal Bank Of Canada upped their price target on shares of Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a research report on Thursday, August 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $170.33.
Read Our Latest Stock Analysis on A
Agilent Technologies Company Profile
Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.
The company’s products and services include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy equipment, laboratory automation tools, software, consumables and supplies.
Featured Stories
- Five stocks we like better than Agilent Technologies
- InvenTrust’s Sell-Off Opens a Potential Entry Point
- Curaleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
- Why onsemi’s Synaptics Pivot Could Be a Game Changer
- AI Chip Demand Gives Linde a New Growth Catalyst
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
